Cardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share
Tweet
Share
E-mailGet Alerts CXM Hot Sheet
Price: $5.91 -5.29%
Revenue Growth %: -1.3%
Financial Fact:
Interest expense: -2.11K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: -1.3%
Financial Fact:
Interest expense: -2.11K
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Cardium Therapeutics, Inc. (NYSE: CXM) reported Q1 EPS of ($0.02), versus ($0.02) reported last year.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Downgrades Woolworths Holdings Ltd (WHL:SJ) to Underweight
- JPMorgan Starts Bechtle AG (BC8:GR) (BECTY) at Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
